Success Stories: Sri Lankan Emerging Technology Field Technical Consultant Secures NIW Approval After RFE for Neuromodulation Research

Case Summary:     

We are pleased to announce the EB-2 NIW approval of an emerging technology field technical consultant from Sri Lanka. At the time of filing, the client was conducting U.S.-based research that integrates machine learning, wearable sensor data, and remote optimization into neuromodulation devices. His goal is to develop personalized therapies for neurological conditions such as Parkinson’s disease and epilepsy. With a record of publications, citations, and international recognition, he presented a compelling case for NIW approval, even after USCIS issued a Request for Evidence (RFE).

Research with Substantial Merit and National Importance

The client’s proposed endeavor focuses on adaptive deep brain stimulation (aDBS) systems that use patient-specific data to optimize treatment. His research has demonstrated methods to improve motor outcomes and sleep quality in Parkinson’s patients, refine therapy responsiveness, and enable remote monitoring outside clinical settings. These breakthroughs carry national importance because neurological conditions affect millions of Americans and generate billions in healthcare costs annually. By advancing precision neuromodulation, his work supports U.S. goals in public health, critical technology development, and healthcare efficiency.

Academic Contributions and Recognition

The client has authored 2 peer-reviewed journal articles, 1 conference paper, and 1 preprint, including a study in Brain Stimulation that ranks among the top 1% most cited works in neuroscience for its publication year. Collectively, his publications have been cited 40 times by independent researchers, with findings adopted in subsequent studies on Parkinson’s therapies and sleep dysfunction. Beyond publishing, he has been mentioned in local news articles that discuss the advances in neurotechnology, further underscoring his recognition as a respected expert in the field.

NIW Approval and Outlook

The I-140 NIW petition was filed on March 26, 2025. USCIS issued an RFE on May 16, 2025, which we successfully addressed with additional evidence of his scholarly record and national impact. The petition was approved on September 1, 2025.

With NAILG’s support, the client secured NIW approval and is now positioned to continue advancing data-driven neuromodulation therapies in the United States. His research promises to transform personalized care for neurological conditions and strengthen U.S. leadership in critical biomedical technologies.